论文部分内容阅读
作者报道了322例严重精神障碍病人(肝功能正常、乙型肝炎血清指标阴性)按0、1、6月全程免疫血源性乙型肝炎疫苗,上臂三角肌注射,每次剂量20μg,首剂免疫后7～8个月及1、2、3和4年后采血测定其抗体滴度,按性别(男171名,女133名)、年龄(≤19、20～29、≥30岁)和体重(≤69、70～109、≥110磅)分析表面抗体的产生和持续情况。第1针后7～8个月有95%抗体阳转(≥2.1S/N),92%的受种者抗体滴度达到保护水平(≥10mIU/ml)。总体几何平均滴度(GMT)为1397mIU/ml,达到保护水平的GMT为2568mIU/ml。女性抗体阳转率及达
The authors reported 322 patients with severe mental disorders (normal liver function, negative serum hepatitis B) by 0,1,6 blood monounsaturated hepatitis B vaccine, upper arm deltoid injection, each dose of 20μg, the first dose The antibody titers were determined by blood sampling 7 to 8 months and 1, 2, 3 and 4 years after immunization. The antibody titers were determined by sex (male 171, female 133), age (≤19,20 ~ 29, ≥30 years) Body weight (≤69, 70 ~ 109, ≥110 pound) Analyze the production and persistence of surface antibodies. Ninety-seven percent of the patients were positive for positive antibody (≥2.1S / N) 7 to 8 months after needle 1, and 92% of those vaccinated patients achieved protection (≥10 mIU / ml). The overall geometric mean titer (GMT) was 1397 mIU / ml and the protection level GMT was 2568 mIU / ml. Female antibody positive rate and up